CHRISTINE SVOBODA: Open Payments
NPI 1942439641 · PAPILLION, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 28 payments from 5 companies in 2025. Trend: 2023 $498 · 2024 $612 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $536 |
| ABBVIE INC. | 17 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: AIRSUPRA, QULIPTA, CAPLYTA, UBRELVY, REXULTI, Veozah, VRAYLAR.
Industry payments across NE — which companies pay providers there.
